AAAAAA

   
Results: 1-18 |
Results: 18
WNT pathway and mammary carcinogenesis: Loss of expression of candidate tumor suppressor gene SFRP1 in most invasive carcinomas except of the medullary type
Authors: Ugolini, F Charafe-Jauffret, E Bardou, VJ Geneix, J Adelaide, J Labat-Moleur, F Penault-Llorca, F Longy, M Jacquemier, J Birnbaum, D Pebusque, MJ
Citation: F. Ugolini et al., WNT pathway and mammary carcinogenesis: Loss of expression of candidate tumor suppressor gene SFRP1 in most invasive carcinomas except of the medullary type, ONCOGENE, 20(41), 2001, pp. 5810-5817
Clinical outcome after front-line intensive sequential chemotherapy (ISC) in patients with aggressive non-Hodgkin's lymphoma and high-risk international prognostic index (IPI 3): Final analysis of survival in two consecutiveISC trials
Authors: Bouabdallah, R Stoppa, AM Coso, D Bardou, VJ Blaise, D Chabannon, C Gastaut, JA Maraninchi, D
Citation: R. Bouabdallah et al., Clinical outcome after front-line intensive sequential chemotherapy (ISC) in patients with aggressive non-Hodgkin's lymphoma and high-risk international prognostic index (IPI 3): Final analysis of survival in two consecutiveISC trials, ANN ONCOL, 12(4), 2001, pp. 513-517
Combined brachytherapy and surgery for early carcinoma of the uterine cervix: Analysis of extent of surgery on outcome
Authors: Resbeut, MR Alzieu, C Gonzague-Casabianca, L Badinand, D Bardou, VJ Cravello, L Gamerre, M Houvenaeghel, G Cowen, D
Citation: Mr. Resbeut et al., Combined brachytherapy and surgery for early carcinoma of the uterine cervix: Analysis of extent of surgery on outcome, INT J RAD O, 50(4), 2001, pp. 873-881
Hodgkin's disease: prognostic role of gallium scintigraphy after chemotherapy
Authors: Brenot-Rossi, I Bouabdallah, R Di Stefano, D Bardou, VJ Stoppa, AM Camerlo, J Sauvan, R Gastaut, JA Pasquier, J
Citation: I. Brenot-rossi et al., Hodgkin's disease: prognostic role of gallium scintigraphy after chemotherapy, EUR J NUCL, 28(10), 2001, pp. 1482-1488
Anal carcinoma: Prognostic value of endorectal ultrasound (ERUS). Results of a prospective multicenter study
Authors: Giovannini, M Bardou, VJ Barclay, R Palazzo, L Roseau, G Helbert, T Burtin, P Bouche, O Pujol, B Favre, O
Citation: M. Giovannini et al., Anal carcinoma: Prognostic value of endorectal ultrasound (ERUS). Results of a prospective multicenter study, ENDOSCOPY, 33(3), 2001, pp. 231-236
Prognostic value of simultaneous expression of p21 and mdm2 in breast carcinomas treated by adjuvant chemotherapy with antracyclin
Authors: Mathoulin-Portier, MP Viens, P Cowen, D Bertucci, F Houvenaeghel, G Geneix, J Puig, B Bardou, VJ Jacquemier, J
Citation: Mp. Mathoulin-portier et al., Prognostic value of simultaneous expression of p21 and mdm2 in breast carcinomas treated by adjuvant chemotherapy with antracyclin, ONCOL REP, 7(3), 2000, pp. 675-680
Local and distant failures after limited surgery with positive margins andradiotherapy for node-negative breast cancer
Authors: Cowen, D Houvenaeghel, G Bardou, VJ Jacquemier, J Bautrant, E Conte, M Viens, P Largillier, R Puig, B Resbeut, M Maraninchi, D
Citation: D. Cowen et al., Local and distant failures after limited surgery with positive margins andradiotherapy for node-negative breast cancer, INT J RAD O, 47(2), 2000, pp. 305-312
High-dose melphalan-based chemotherapy and autologous stem cell transplantation after second look laparotomy in patients with chemosensitive advancedovarian carcinoma: long-term results
Authors: Bertucci, F Viens, P Delpero, JR Bardou, VJ Faucher, C Houvenaeghel, G Maraninchi, D
Citation: F. Bertucci et al., High-dose melphalan-based chemotherapy and autologous stem cell transplantation after second look laparotomy in patients with chemosensitive advancedovarian carcinoma: long-term results, BONE MAR TR, 26(1), 2000, pp. 61-67
Role of high-dose therapy and initial response in survival of poor-risk patients with aggressive non-Hodgkin's lymphoma: a retrospective series on 126 patients from a single center
Authors: Bouabdallah, R Coso, D Costello, R Bardou, VJ Blaise, D Xerri, L Sainty, D Maraninchi, D Gastaut, JA
Citation: R. Bouabdallah et al., Role of high-dose therapy and initial response in survival of poor-risk patients with aggressive non-Hodgkin's lymphoma: a retrospective series on 126 patients from a single center, BONE MAR TR, 25(1), 2000, pp. 35-40
Prognosis of breast-carcinoma lymphagenesis evaluated by immunohistochemical investigation of vascular-endothelial-growth-factor receptor 3
Authors: Jacquemier, J Mathoulin-Portier, MP Valtola, R Charafe-Jauffret, E Geneix, J Houvenaeghel, G Puig, B Bardou, VJ Hassoun, J Viens, P Birnbaum, D
Citation: J. Jacquemier et al., Prognosis of breast-carcinoma lymphagenesis evaluated by immunohistochemical investigation of vascular-endothelial-growth-factor receptor 3, INT J CANC, 89(1), 2000, pp. 69-73
Relation between endoscopic ultrasound evaluation and survival of patientswith inoperable thoracic squamous cell carcinoma of the oesophagus treatedby combined radio- and chemotherapy
Authors: Giovannini, M Bardou, VJ Moutardier, V Bernardini, D Resbeut, M Capodano, G Seitz, JF
Citation: M. Giovannini et al., Relation between endoscopic ultrasound evaluation and survival of patientswith inoperable thoracic squamous cell carcinoma of the oesophagus treatedby combined radio- and chemotherapy, ITAL J GAST, 31(7), 1999, pp. 593-597
Differential MUC 1 expression in normal and neoplastic human pancreatic tissue - An immunohistochemical study of 60 samples
Authors: Monges, GM Mathoulin-Portier, MPA Acres, RB Houvenaeghel, GF Giovannini, MF Seitz, JF Bardou, VJ Payan, MJM Olive, D
Citation: Gm. Monges et al., Differential MUC 1 expression in normal and neoplastic human pancreatic tissue - An immunohistochemical study of 60 samples, AM J CLIN P, 112(5), 1999, pp. 635-640
Intensive sequential chemotherapy (ISC 95) with growth factors and blood stem cell support in high-intermediate and high-risk (IPI 2 and IPI 3) aggressive non-Hodgkin's lymphoma: an oligocentric report on 42 patients
Authors: Bouabdallah, R Stoppa, AM Rossi, JF Lepeu, G Coso, D Xerri, L Ladaique, P Chabannon, C Blaise, D Bardou, VJ Alzieu, C Gastaut, JA Maraninchi, D
Citation: R. Bouabdallah et al., Intensive sequential chemotherapy (ISC 95) with growth factors and blood stem cell support in high-intermediate and high-risk (IPI 2 and IPI 3) aggressive non-Hodgkin's lymphoma: an oligocentric report on 42 patients, LEUKEMIA, 13(6), 1999, pp. 950-956
High-dose chemotherapy with hematopoietic stem cell support in patients with advanced epithelial ovarian cancer: Analysis of 67 patients treated in asingle institution
Authors: Bertucci, F Viens, P Gravis, G Blaise, D Faucher, C Oziel-Taoeb, S Bardou, VJ Jacquemier, J Delpero, JR Maraninchi, D
Citation: F. Bertucci et al., High-dose chemotherapy with hematopoietic stem cell support in patients with advanced epithelial ovarian cancer: Analysis of 67 patients treated in asingle institution, ANTICANC R, 19(2B), 1999, pp. 1455-1461
Peritumoral vascular invasion in women with node-negative breast cancer, receiving no adjuvant therapy
Authors: Mathoulin-Portier, MP Meynard, P Charton-Bain, MC Escoute, M Bardou, VJ Puig, B Viens, P Cowen, D Houvenaeghel, G Hassoun, J Jacquemier, J
Citation: Mp. Mathoulin-portier et al., Peritumoral vascular invasion in women with node-negative breast cancer, receiving no adjuvant therapy, ANTICANC R, 19(1B), 1999, pp. 843-847
Association of angiogenesis and poor prognosis in node-positive patients receiving anthracycline-based adjuvant chemotherapy
Authors: Viens, P Jacquemier, J Bardou, VJ Bertucci, F Penault-Llorca, F Puig, B Gravis, G Oziel-Taieb, S Resbeut, M Houvenaeghel, G Camerlo, J Birbaum, D Hassoun, J Maraninchi, D
Citation: P. Viens et al., Association of angiogenesis and poor prognosis in node-positive patients receiving anthracycline-based adjuvant chemotherapy, BREAST CANC, 54(3), 1999, pp. 205-212
Novel indications for BRCA1 screening using individual clinical and morphological features
Authors: Eisinger, F Nogues, C Guinebretiere, JM Peyrat, JP Bardou, VJ Noguchi, T Vennin, P Sauvin, R Lidereau, R Birnbaum, D Jacquemier, J Sobol, H
Citation: F. Eisinger et al., Novel indications for BRCA1 screening using individual clinical and morphological features, INT J CANC, 84(3), 1999, pp. 263-267
First-line high-dose sequential chemotherapy with rG-CSF and repeated blood stem cell transplantation in untreated inflammatory breast cancer: toxicity and response (PEGASE 02 trial)
Authors: Viens, P Palangie, T Janvier, M Fabbro, M Roche, H Delozier, T Labat, JP Linassier, C Audhuy, B Feuilhade, F Costa, B Delva, R Cure, H Rousseau, F Guillot, A Mousseau, M Ferrero, JM Bardou, VJ Jacquemier, J Pouillart, P
Citation: P. Viens et al., First-line high-dose sequential chemotherapy with rG-CSF and repeated blood stem cell transplantation in untreated inflammatory breast cancer: toxicity and response (PEGASE 02 trial), BR J CANC, 81(3), 1999, pp. 449-456
Risultati: 1-18 |